Effect of prescription refill on quality of care among patients with type 2 diabetes: An exploratory study

Diabetes Research and Clinical Practice

Volumn 105, Issue 1, 2014, Pages 110-118

  Wang, Jong Yi ^a   Lee, Shu Hui ^b   Lee, I Te ^b,c   Chen, Jen De ^d   Sheu, Wayne Huey Herng ^b,e,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Diabetes; Glycemic control; Prescription refill; Quality of care; Treatment outcome

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRESCRIPTION; PRESCRIPTION REFILL; RETROSPECTIVE STUDY;

DIABETES; GLYCEMIC CONTROL; PRESCRIPTION REFILL; QUALITY OF CARE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HEALTH EXPENDITURES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84902540376     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.04.001     Document Type: Article

References (32)

1. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:293-301.
2. Department of Health Statistics of major causes of death. January 2013 2011, Available from: http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d=84765&s=1 [accessed 3.02.13].
3. The China Post Cancer is nation's top killer: DOH June 2011, Available from: http://www.chinapost.com.tw/taiwan/national/national-news/2011/06/16/306416/Cancer-is.htm [accessed 30.12.12].
4. Turner R.C., Holman R.R., Cull C.A., Stratton I.M., Matthews D.R., Frighi V., et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853.
5. Stratton I.M., Cull C.A., Adler A.I., Matthews D.R., Neil H.A.W., Holman R.R. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006, 49:1761-1769.
6. Lee T.T., Cheng S.H., Chen C.C., Lai M.S. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am J Manag Care 2010, 16:65-69.
7. Yu N.C., Su H.Y., Tsai S.T., Lin B.J., Shiu R.S., Hsieh Y.C., et al. ABC control of diabetes: survey data from National Diabetes Health Promotion Centers in Taiwan. Diabetes Res Clin Pract 2009, 84:194-200.
8. Taitel M., Fensterheim L., Kirkham H., Sekula R., Duncan I. Medication days' supply, adherence, wastage, and cost among chronic patients in medicaid. Medicare Medicaid Res Rev 2012, 2:E1-E12.
9. Department of Health Regulations for NHI medical care January 2013, Available from: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=&menu_id=&wd_id=&webdata_id=2430 [accessed 20.01.13].
10. Kindmalm L., Melander A., Nilsson J.L.G. Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1c) in patients with type 2 diabetes. Acta Diabetol 2007, 44:209-213.
11. Kim N., Agostini J.V., Justice A.C. Refill adherence to oral hypoglycemic agents and glycemic control in veterans. Ann Pharmacother 2010, 44:800-808.
12. Rosenaur J., Stanford D., Morgan W., Curtin B. Prescribing behaviors of primary care nurse practitioners. Am J Public Health 1984, 74:10-13.
13. Schneider P.J., Murphy J.E., Pedersen C.A. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc 2008, 48:58-63.
14. Berenguer B., La Casa C., de la Matta M.J., Martin-Calero M.J. Pharmaceutical care: past, present and future. Curr Pharm Des 2004, 10:3931-3946.
15. Armstrong E., Langley P. Treatment of pneumonias in a managed-care organisation: the impact of a treatment guideline promotion on physician prescribing behaviour. Dis Manag Health Outcome 1999, 6:159-173.
16. Schwartzberg E., Rubinovich S., Hassin D., Haspel J., Ben-Moshe A., Oren M., et al. Developing and implementing a model for changing physicians' prescribing habits-the role of clinical pharmacy in leading the change. J Clin Pharm Ther 2006, 31:179-185.
17. American Diabetes Association Executive summary: standards of medical care in diabetes-2010. Diabetes Care 2010, 33(Suppl. 1):S4-S10.
18. Donabedian A. The quality of care, how can it be assessed?. JAMA 1988, 260:1743-1748.
19. International Diabetes Federation Guideline Development Group Global guideline for type 2 diabetes. Diabetes Res Clin Pract 2014, 10.1016/j.diabres.2012.10.001.
20. Turchin A., Shubina M., Pendergrass M.L. Relationship of physician volume with process measures and outcomes in diabetes. Diabetes Care 2007, 30:1442-1447.
21. Chang C.H., Shau W.Y., Jiang Y.D., Li H.Y., Chang T.J., Sheu W.H.H., et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabet Med 2010, 27:636-643.
22. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998, 317:703-713.
23. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986.
24. Basevi V., Di Mario S., Morciano C., Nonino F., Magrini N. Comment on: American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011, 34(Suppl. 1):S11-S61. [Diabetes Care 2011;34:e53].
25. Holmboe E.S., Wang Y., Tate J.P., Meehan T.P. The effects of patient volume on the quality of diabetic care for Medicare beneficiaries. Med Care 2006, 44:1073-1077.
26. Wang J.S., Lin S.Y., Sheu W.H., Lee I.T., Tseng L.N., Song Y.M. Effects of patient volume on quality of outpatient diabetes care. Diabetes Res Clin Pract 2009, 84:e27-e29.
27. Lee T., Cheng S., Chen C., Lai M. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am J Manag Care 2010, 16:65-69.
28. Ng T., Goh L., Tan Y., Tan E., Leong H., Tay E., et al. Ethnic differences in glycaemic control in adult type 2 diabetic patients in primary care: a 3-year follow-up study. Diabet Med 2005, 22:1598-1604.
29. Moorhead R. Sharing care between allied health professionals and general practitioners. Aust Fam Physician 1995, 24:1985.
30. Greenhalgh P.M. Shared care for diabetes. A systematic review. Occas Pap R Coll Gen Pract 1994, i-viii.
31. Martens J.D., Werkhoven M.J., Severens J.L., Winkens R.A.G. Effects of a behaviour independent financial incentive on prescribing behaviour of general practitioners. J Eval Clin Pract 2007, 13:369-373.
32. Liu Y.M., Yang Y.H., Hsieh C.R. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. J Health Econ 2009, 28:341-349.